Vaccine row escalates as France accuses UK of ‘blackmail’

A pharmacist prepares an AstraZeneca Covid-19 vaccine with a syringe in Nantes, western France. (AFP)
Short Url
Updated 26 March 2021
Follow

Vaccine row escalates as France accuses UK of ‘blackmail’

  • Latest EU-UK row centres on an AstraZeneca plant in the Netherlands, which Boris Johnson's government claims as part of the British vaccine supply chain
  • Macron said after the EU summit “We are looking in particular at Russian and Chinese attacks and attempts to gain influence through the vaccine”

PARIS – A row over Covid-19 vaccine access escalated Friday, with France accusing Britain of “blackmail” in its dealings with the EU, and Russia and China of misusing vaccines to boost their foreign policy clout.
French Foreign Minister Jean-Yves Le Drian’s salvo came a day after the European Union threatened to ban pharma firms from exporting coronavirus vaccines to the UK and other well-supplied countries until they make good on their promised deliveries to the bloc.
British-based AstraZeneca would likely be the first target of any such restrictions.
The UK was under pressure because it lacked doses for second vaccine shots, said Le Drian.
“The United Kingdom has taken great pride in vaccinating well with the first dose except they have a problem with the second dose,” he told France Info radio.
“You are vaccinated when you have had both doses. Today there are as many people vaccinated with both in France as the United Kingdom,” he added.
According to data compiled by AFP, Britain has administered two vaccine doses to 4.1 percent of its population, against 3.9 percent overall in France.
“You can’t be playing like this, a bit of blackmail, just because you hurried to get people vaccinated with a first shot, and now you’re a bit handicapped because you don’t have the second one,” Le Drian added.
Le Drian did not say what precisely constituted the alleged British blackmail, but Prime Minister Boris Johnson had warned earlier in the week that trade “blockades” would chill investment.
“I would just gently point out to anybody considering a blockade, or interruption of supply chains, that companies may look at such actions and draw conclusions about whether or not it is sensible to make future investments in countries where arbitrary blockades are imposed,” he told lawmakers.
The latest EU-UK row centers on an AstraZeneca plant in the Netherlands, which Johnson’s government claims as part of the British vaccine supply chain.
Any suggestions of British vaccine selfishness have found robust responses in British media, with The Times accusing President Emmanuel Macron of “evident anglophobia” and “petty jingoism,” and The Sun calling him “arrogant.”
EU chief Ursula von der Leyen’s stark warning of a vaccine export stop came after a video summit of all 27 EU leaders and stoked fears that cross-Channel rivalry could damage global efforts to combat the pandemic.
France has made clear it sees vaccine policies feeding not just European, but global competition for influence.
“We are looking at a new type of world war,” Macron said after the EU summit. “We are looking in particular at Russian and Chinese attacks and attempts to gain influence through the vaccine.”
This situation, he said, meant the EU had to strengthen its own vaccine capabilities.
His foreign minister on Friday also accused Russia and China of using their vaccines to gain influence abroad even before they had finished inoculating their own populations, a claim rejected by Moscow.
“We absolutely disagree with the fact that both Russia and China are waging some kind of war,” Kremlin spokesman Dmitry Peskov told journalists.
“And we absolutely disagree with the fact that Russia and China are using the coronavirus pandemic and vaccines as tools of influence.”
Russia and China have, for their part, accused Western countries of hoarding vaccines to the detriment of poor nations.
Russia has applied to Europe’s medicines regulator EMA to gain approval for the use of its Sputnik V vaccine in the 27-nation bloc, but is still waiting for an answer.
The German government said Friday that it would be open to using Sputnik V once it had EMA approval.
In the meantime the developers are pushing Sputnik V — named after the Soviet-era satellite — in other regions and say the jab has been registered in 55 countries around the world.


Oman’s economy grows 2% in Q3 as bank credit expands 

Updated 5 sec ago
Follow

Oman’s economy grows 2% in Q3 as bank credit expands 

JEDDAH: Oman’s economy expanded 2 percent in the third quarter of 2025, supported by steady growth in non-oil activities, while bank lending continued to rise faster than deposits, underscoring improving domestic demand. 

Gross domestic product at constant prices reached about 9.91 billion Omani rials ($26 billion) in the three months through September, up from 9.71 billion rials a year earlier, according to preliminary data from the National Centre for Statistics and Information. 

The expansion was driven mainly by non-oil sectors, where value added increased 2 percent to more than 7.3 billion rials, Oman News Agency reported. 

This comes after Fitch Ratings recently upgraded the Sultanate’s sovereign credit rating to investment grade at BBB-, projecting GDP growth of around 4 percent in 2025, driven largely by robust expansion in the non-oil sector. 

Meanwhile, S&P Global Ratings expects steady real GDP growth of about 2 percent a year through 2028, supported by ongoing economic diversification and momentum in the services sector. 

“By economic activity, construction activities grew 1.3 percent to around 1.035 billion rials, while wholesale and retail trade increased 1.3 percent to 830.5 million rials. Public administration and defense rose 1.5 percent, reaching 932.5 million rials in Q3 2025,” the ONA report stated. 

Oil sector activities increased 1.9 percent to nearly 3.07 billion rials, compared with just over 3.01 billion rials in the same period of 2024. Crude oil production rose 2 percent to more than 2.55 billion rials, while natural gas activities grew 1.6 percent to 512.8 million rials, up from 504.7 million rials a year earlier. 

Meanwhile, total credit extended by conventional commercial banks in the Sultanate rose 8.5 percent by the end of November, with lending to the private sector increasing 5.8 percent to 21.9 billion rials. 

“In terms of investment, total holdings of conventional commercial banks in securities grew 7.4 percent, reaching approximately 6.4 billion rials by the end of November 2025,” ONA stated in another report. 

Within this category, investments in government development bonds rose 9.5 percent year on year to 2.2 billion rials, while investments in foreign securities declined 4.4 percent to 2.3 billion rials. 

On the liabilities side, total deposits with conventional commercial banks increased 6.3 percent to 26.4 billion rials by the end of November. 

Among total deposits, government deposits rose 7.6 percent to about 5.8 billion rials, while deposits from public sector institutions fell 25.6 percent to roughly 1.9 billion rials. 

Private sector deposits climbed 9.5 percent to 17.8 billion rials in November, accounting for 67.2 percent of total deposits with conventional commercial banks.